Department of Physiology and Biophysics, Institute of Biology, University of Campinas, P.O. Box 6019, 13083-970, Campinas, SP, Brazil.
Placenta. 2011 Nov;32(11):859-64. doi: 10.1016/j.placenta.2011.08.009. Epub 2011 Sep 7.
Placental dysfunction leads to foetal damage, which jeopardises the exchange between the maternal and foetal systems. We evaluated the effects of tumour growth on the activity of antioxidant enzymes and oxidative stress in placental tissue and cell culture from tumour-bearing pregnant rats compared to non-tumour-bearing pregnant rats that were ascitic fluid injected. Ascitic fluid is obtained from Walker tumour-bearing rats and contains a cytokine called Walker factor (WF), which is a molecule similar to proteolysis-inducing factor (PIF), and induces changes in protein metabolism and oxidative stress. Pregnant Wistar rats were distributed into control (C), tumour-bearing (W) and ascitic fluid injected (A) groups and were sacrificed on days 16, 19 and 21 of pregnancy to analyse the profile of enzyme activities (glutathione-S-transferase (GST), catalase (CAT), alkaline phosphatase (AP)) and malondialdehyde (MDA) content in placental tissue. Meanwhile, placenta samples from all groups were obtained on day 21, placed in primary culture and treated with WF for 72 h. The presence of tumour or ascitic fluid reduced the protein content of the placental tissue. On day 16 there was a significant reduction in AP activity in W rats, and on day 19, CAT activity and MDA content significantly increased. These results indicate that the presence of cancer decreased antioxidant enzyme capacity in the placenta, increasing the amount of oxidation in these cells, which may contribute to irreversible placental damage and compromisefoetal development. WF treatment induces similar changes in placental cells in primary culture, resulting in less cell viability and increased oxidative stress. These results indicate that WF, provided by the tumour or inoculation of ascitic fluid, has negative effects on placental homeostasis, which impairs foetal health.
胎盘功能障碍导致胎儿损伤,危及母体和胎儿系统之间的交换。我们评估了肿瘤生长对胎盘组织和细胞培养中抗氧化酶活性和氧化应激的影响,比较了荷瘤怀孕大鼠与接受腹水注射的非荷瘤怀孕大鼠。腹水取自 Walker 荷瘤大鼠,含有一种称为 Walker 因子 (WF) 的细胞因子,它是一种类似于蛋白水解诱导因子 (PIF) 的分子,可诱导蛋白代谢和氧化应激的变化。怀孕 Wistar 大鼠分为对照组 (C)、荷瘤组 (W) 和腹水注射组 (A),并在妊娠第 16、19 和 21 天处死,以分析胎盘组织中酶活性(谷胱甘肽-S-转移酶 (GST)、过氧化氢酶 (CAT)、碱性磷酸酶 (AP))和丙二醛 (MDA) 含量的特征。同时,在第 21 天获得所有组别的胎盘样本,置于原代培养中,并使用 WF 处理 72 小时。肿瘤或腹水的存在降低了胎盘组织的蛋白质含量。第 16 天,W 组的 AP 活性显著降低,第 19 天,CAT 活性和 MDA 含量显著增加。这些结果表明,癌症的存在降低了胎盘的抗氧化酶能力,增加了这些细胞的氧化量,这可能导致胎盘不可逆损伤和胎儿发育受损。WF 处理在原代培养的胎盘细胞中诱导类似的变化,导致细胞活力降低和氧化应激增加。这些结果表明,肿瘤或接种腹水提供的 WF 对胎盘内稳态产生负面影响,损害胎儿健康。